Order Entry
Canada
ContactUsLinkComponent
SensoLyte® 520 Rat Renin Assay Kit (Fluorimetric), AnaSpec
SensoLyte® 520 Rat Renin Assay Kit (Fluorimetric), AnaSpec
Catalog # 103010-482
Supplier:  Anaspec Inc
CAS Number:  
SensoLyte® 520 Rat Renin Assay Kit (Fluorimetric), AnaSpec
Catalog # 103010-482
Supplier:  Anaspec Inc
Supplier Number:  AS-72140
CAS Number:  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/ca/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

Specifications

  • Size:
    100 Assays
  • Cat. no.:
    103010-482
  • Storage Temperature:
    – 78 °C
  • Includes:
    The assays can be performed in a convenient 96-well microplate format, kit includes essential components and detailed protocol and references
  • Supplier No.:
    AS-72140

Specifications

About this item

Renin, a highly specific aspartyl protease, cleaves angiotensinogen, to yield angiotensin I, which is further converted into angiotensin II by ACE (Angiotensin Converting Enzyme)

The SensoLyte® 520 Rat Renin Assay Kit provides a convenient assay for high throughput screening of renin inhibitors and for continuous assay of renin activity using a 5-FAM/QXL®520 fluorescence resonance energy transfer (FRET) peptide. In the FRET peptide the fluorescence of 5-FAM is quenched by QXL®520. Upon cleavage into two separate fragments by renin, the fluorescence of 5-FAM is recovered, and can be monitored at excitation/emission = 490/520 nm.

Angiotensin II constricts blood vessels leading to increased blood pressure. Discovery of new renin inhibitors for treatment of hypertension is a promising area of research.